ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 538,29
-0,30%
Dow Jones
39 331,85
0,41%
DAX
18 164,06
-0,86%
Brent Oil
86,445
-0,10%
Bitcoin
62 062,94
-1,25%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Turnstone Biologics Corporation (TSBX)

  7. Turnstone Biologics Corporation (TSBX) Actualités

TSBX

Turnstone Biologics (TSBX)

Turnstone Biologics Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TSBX
DateHeureSourceTitreSymboleSociété
05/06/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
31/05/202422h23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TSBXTurnstone Biologics Corporation
13/05/202423h15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TSBXTurnstone Biologics Corporation
13/05/202423h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
13/05/202423h01GlobeNewswire Inc.Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
08/05/202415h00GlobeNewswire Inc.Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
16/04/202415h00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:TSBXTurnstone Biologics Corporation
21/03/202422h06GlobeNewswire Inc.Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
21/02/202412h00GlobeNewswire Inc.Turnstone Biologics to Participate in Upcoming Investor ConferencesNASDAQ:TSBXTurnstone Biologics Corporation
20/02/202423h00GlobeNewswire Inc.Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.NASDAQ:TSBXTurnstone Biologics Corporation
27/11/202312h00GlobeNewswire Inc.Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
10/11/202303h49GlobeNewswire Inc.Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
03/11/202311h00GlobeNewswire Inc.Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
30/10/202311h00GlobeNewswire Inc.Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. WeberNASDAQ:TSBXTurnstone Biologics Corporation
18/10/202300h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
28/09/202312h00GlobeNewswire Inc.Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
01/09/202323h57GlobeNewswire Inc.Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TSBXTurnstone Biologics Corporation
21/07/202308h15GlobeNewswire Inc.Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public OfferingNASDAQ:TSBXTurnstone Biologics Corporation
 Showing the most relevant articles for your search:NASDAQ:TSBX

Dernières Valeurs Consultées

NASDAQ
NVDA
NVIDIA
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
EU
VK
Vallourec
EU
ORA
Orange
NASDAQ
AAPL
Apple
EU
DG
Vinci
EU
GLE
Societe Generale
EU
RI
Pernod Ricard
NASDAQ
GOOGL
Alphabet
EU
BEL20
Bel 20
EU
CS
Axa
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés